Dopamine rushes, withdrawals, and detoxes are trending among wellness gurus online. But experts say the science behind the ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

Brain implants, made from small clusters of brain cells, could help restore neural pathways damaged by Parkinson’s disease.

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

The global Parkinson’s disease (PD) market is expected to grow to $7.9 billion by 2033 from $3.4 billion in 2023, according ...

The US Food and Drug Administration (FDA) has approved Supernus Pharmaceuticals’ Onapgo (apomorphine hydrochloride) injection ...

The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

Researchers in India have developed a new nanoformulation that may improve the safety and efficacy of Parkinson's disease treatment, IANS, a partner ...

The LXM.5 pilot study reveals an 80% bioavailability increase compared to competing products combining levodopa and carbidopa. The study additionally shows sustained and smooth levodopa levels in the ...

This disease most often develops after age 50. Nerve cells use a brain chemical called dopamine to help control muscle movement. Parkinson's disease occurs when the nerve cells in the brain that ...

There’s no cure for restless legs syndrome – a distressing disorder that mainly affects sufferers at night – but there are ...

The symptoms of Parkinson’s disease could be reversed through injections of nanoparticles into the brain, which is a much ...